Clinical Trial Detail

NCT ID NCT02400281
Title Study of Crenolanib Combined With Chemotherapy in FLT3-mutated Acute Myeloid Leukemia Patients
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Arog Pharmaceuticals, Inc.
Indications

bone marrow cancer

acute myeloid leukemia

Therapies

Azacitidine

Crenolanib

Cytarabine + Idarubicin

Age Groups: adult

Additional content available in CKB BOOST